Classification of TP53 Mutations and HPV Predict Survival in Advanced Larynx Cancer

OBJECTIVE: Assess TP53 functional mutations in the context of other biomarkers in advanced larynx cancer. STUDY DESIGN: Prospective analysis of pretreatment tumor TP53, HPV, Bcl-xL and cyclin D1 status in stage III and IV larynx cancer patients in a clinical trial. METHODS: TP53 exons 4-9 from 58 tu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Laryngoscope
Auteurs principaux: Scheel, Adam, Bellile, Emily, McHugh, Jonathan B., Walline, Heather M., Prince, Mark E., Urba, Susan, Wolf, Gregory T., Eisbruch, Avraham, Worden, Francis, Carey, Thomas E., Bradford, Carol
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5002993/
https://ncbi.nlm.nih.gov/pubmed/27345657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.25915
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires